Drugs / TTP054
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01665352 | Aug 2012 → May 2013 | type 2 diabetes mellitus | vTv Therapeutics | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2012-11-01 | vTv Therapeutics | TTP054, a Novel, Orally Active Drug for Glucose Control, Progresses Towards Completion of a Phase 2 Proof-of-Concept Clinical Trial in Type 2 Diabetics vtvtherapeutics.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TTP054 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01665352 ↗ |
| Route | Oral | “Administered orally once daily for 12 weeks.” NCT01665352 ↗ |